When Air and Surface Purification is a Must,
Our Premium Solution Does Not Compromise

Today’s healthcare environments and large commercial spaces deserve hospital-grade solutions designed to offer a premium disinfection solution. CASPR Medik™ is clinically proven to reduce pathogens to up to 99.96% throughout hospitals, clinics and other large commercial facilities.

Using a patented technology our products are designed to be seamlessly installed in HVAC ducts, providing continuous disinfection in any space. And, our products can be used safely in occupied spaces, with no need to remove occupants, patients, visitors or staff, or to seal rooms.

When Air and Surface Purification is a Must,
Our Premium Solution Does Not Compromise

Today’s healthcare environments and large commercial spaces deserve hospital-grade solutions designed to offer a premium disinfection solution. CASPR Medik™ is clinically proven to reduce pathogens to up to 99.96% throughout hospitals, clinics and other large commercial facilities.

Using a patented technology our products are designed to be seamlessly installed in HVAC ducts, providing continuous disinfection in any space. And, our products can be used safely in occupied spaces, with no need to remove occupants, patients, visitors or staff, or to seal rooms.

CASPR Medik The Hospital-Grade Air and Surface Purifier

CASPR Medik™ is our medical-grade solution that provides constant, stable levels of hydrogen peroxide to targeted areas. Units are inserted into existing HVAC ducts where they will reacts with your ambient air to create low levels of hydrogen peroxide (between .01 and .04 ppm). These molecules then circulate the air, land on all surfaces, and actively reduce micro-burdens as soon as contamination occurs. CASPR’s continuous nature allows us to not only reduce the Colony Forming Units (CFUs) but it keeps them down by preventing them from multiplying in-between episodic cleaning and disinfecting.
CASPR-Medik-Unit

CASPR Medik The Hospital-Grade Air and Surface Purifier

CASPR Medik™ is our medical-grade solution that provides constant, stable levels of hydrogen peroxide to targeted areas. Units are inserted into existing HVAC ducts where they will reacts with your ambient air to create low levels of hydrogen peroxide (between .01 and .04 ppm). These molecules then circulate the air, land on all surfaces, and actively reduce micro-burdens as soon as contamination occurs. CASPR’s continuous nature allows us to not only reduce the Colony Forming Units (CFUs) but it keeps them down by preventing them from multiplying in-between episodic cleaning and disinfecting.
CASPR-Medik-Unit

No-Touch Technology That’s Truly No-Touch

CASPR Medik allows you to protect your patients and staff from the moment they step foot into your facility. CASPR’s continuous air and surface pathogen reduction technology offers no touch, facility-wide, enhanced disinfection. CASPR technology used in occupied spaces has helped hospitals and large commercial buildings improve their throughput times and reduce employee absenteeism by over 40%.

No-Touch Technology That’s Truly No-Touch

CASPR Medik allows you to protect your patients and staff from the moment they step foot into your facility. CASPR’s continuous air and surface pathogen reduction technology offers no touch, facility-wide, enhanced disinfection. CASPR technology used in occupied spaces has helped hospitals and large commercial buildings improve their throughput times and reduce employee absenteeism by over 40%. 

CASPR Medik Proven Results

CASPR has been proven effective against relevant pathogens in both independent laboratory settings and hospital trials. In our latest studies, we were able to reduce employee absenteeism by 42% year-over-year at one hospital and reduce HAIs by 53% at another hospital.

 

CASPR Medik Proven Results

CASPR has been proven effective against relevant pathogens in both independent laboratory settings and hospital trials. In our latest studies, we were able to reduce employee absenteeism by 42% year-over-year at one hospital and reduce HAIs by 53% at another hospital.

MRSA

Clostridium difficile

VRE

Aspergillus Niger

 

 

Applications